TY - JOUR AU - Carmona-Rivera, Carmelo AU - Purmalek, Monica M. AU - Moore, Erica AU - Waldman, Meryl AU - Walter, Peter J. AU - Garraffo, H. Martin AU - Phillips, Karran A. AU - Preston, Kenzie L. AU - Graf, Jonathan AU - Kaplan, Mariana J. AU - Grayson, Peter C. T1 - A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity PY - 2017/02/09/ AB - Levamisole, an anthelmintic drug with cholinergic properties, has been implicated in cases of drug-induced vasculitis when added to cocaine for profit purposes. Neutrophil extracellular trap (NET) formation is a cell death mechanism characterized by extrusion of chromatin decorated with granule proteins. Aberrant NET formation and degradation have been implicated in idiopathic autoimmune diseases that share features with levamisole-induced autoimmunity as well as in drug-induced autoimmunity. This study’s objective was to determine how levamisole modulates neutrophil biology and its putative effects on the vasculature. Murine and human neutrophils exposed to levamisole demonstrated enhanced NET formation through engagement of muscarinic subtype 3 receptor. Levamisole-induced NETosis required activation of Akt and the RAF/MEK/ERK pathway, ROS induction through the nicotinamide adenine dinucleotide phosphate oxidase, and peptidylarginine deiminase activation. Sera from two cohorts of patients actively using levamisole-adulterated cocaine displayed autoantibodies against NET components. Cutaneous biopsy material obtained from individuals exposed to levamisole suggests that neutrophils produce NETs in areas of vasculitic inflammation and thrombosis. NETs generated by levamisole were toxic to endothelial cells and impaired endothelium-dependent vasorelaxation. Stimulation of muscarinic receptors on neutrophils by cholinergic agonists may contribute to the pathophysiology observed in drug-induced autoimmunity through the induction of inflammatory responses and neutrophil-induced vascular damage. JF - JCI Insight JA - JCI Insight SN - 2379-3708 DO - 10.1172/jci.insight.89780 VL - 2 IS - 3 UR - https://doi.org/10.1172/jci.insight.89780 PB - The American Society for Clinical Investigation ER -